Ftse Mib
34.374,77
0,00%
DAX
20.024,66
0,58%
S&P 500
5.868,55
-0,22%
NASDAQ
19.280,79
-0,16%
Bitcoin
96.770,51
-0,13%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Adhera Therapeutics Inc (CE) (ATRX) Adhera Therapeutics Inc (CE) (ATRX) Notizie

ATRX

Adhera Therapeutics (CE) (ATRX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ATRX
DataOraFonteTitoloSimboloCompagnia
30/01/202422:00Edgar (US Regulatory)Form SEC STAFF ACTION - SEC Staff Action: ORDERUSOTC:ATRXAdhera Therapeutics Inc (CE)
18/01/202422:25Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ATRXAdhera Therapeutics Inc (CE)
20/11/202322:51Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ATRXAdhera Therapeutics Inc (CE)
15/11/202322:35Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ATRXAdhera Therapeutics Inc (CE)
22/05/202321:14Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ATRXAdhera Therapeutics Inc (CE)
05/05/202322:03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ATRXAdhera Therapeutics Inc (CE)
31/03/202321:17Edgar (US Regulatory)Annual Report (10-k)USOTC:ATRXAdhera Therapeutics Inc (CE)
02/12/202223:08Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ATRXAdhera Therapeutics Inc (CE)
18/08/202218:48Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:ATRXAdhera Therapeutics Inc (CE)
17/06/202222:02Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:ATRXAdhera Therapeutics Inc (CE)
29/04/202222:58Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:ATRXAdhera Therapeutics Inc (CE)
21/04/202222:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ATRXAdhera Therapeutics Inc (CE)
01/04/202222:02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ATRXAdhera Therapeutics Inc (CE)
16/11/202122:05Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ATRXAdhera Therapeutics Inc (CE)
11/05/202122:22Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:ATRXAdhera Therapeutics Inc (CE)
19/02/202015:57Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:ATRXAdhera Therapeutics Inc (CE)
19/11/201923:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ATRXAdhera Therapeutics Inc (CE)
05/11/201920:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ATRXAdhera Therapeutics Inc (CE)
31/10/201921:58Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)USOTC:ATRXAdhera Therapeutics Inc (CE)
26/09/201922:25Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)USOTC:ATRXAdhera Therapeutics Inc (CE)
20/08/201923:02Edgar (US Regulatory)Tender Offer Statement by Issuer (sc To-i)USOTC:ATRXAdhera Therapeutics Inc (CE)
03/05/201923:08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:ATRXAdhera Therapeutics Inc (CE)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ATRX

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
SPM
Saipem
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
IVG
Iveco Group NV
BIT
BAMI
Banco BPM
BIT
TEN
Tenaris
BIT
MONC
Moncler
BIT
SRG
Snam
BIT
CPR
Davide Campari
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network